Back to device advisories
FDA device recallVulnerabilitiesPublished Oct 23, 2025

Tandem Diabetes Care, Inc.: Alternate Controller Enabled Insulin Infusion Pump

Updated 4 hours ago ()

A software defect in versions 7.9.0.1 and 7.10.1 of the pump software for Tandem t:slim X2 and version 7.9.0.1 of the Tandem Mobi pump with Control-IQ+ technology that are paired with a G7 sensor may result in an unexpected automatic insulin correction bolus (autobolus ) which could result in hypoglycemia.

Tags
FDA recall, medical device, class 2, Clinical Chemistry, Software change control, Open, Classified
Related exam domains
CISSP 3: Security Architecture and Engineering; CISSP 8: Software Development Security; CISM 3: Information Security Program
Source record id
Z-0232-2026
First seen by InfoSec Signals
Sep 23, 2026

Source: openFDA device recalls, U.S. Food and Drug Administration about this source more from it

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.